HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

ovide those resources in part by building the necessary facilities, establishing collaborations with industry, and training new scientists with varying expertise.

Many goals presented in the Research Agenda build on the results of ongoing NIAID research. New smallpox, Ebola and anthrax vaccines have been developed by NIAID researchers or grantees and are now approaching clinical testing. One of the first drugs to help treat smallpox was recently submitted to the FDA for approval, and two recent studies identified important biochemical features of two different anthrax toxins that have provided promising leads for new anthrax drugs. Over the past several years, NIAID scientists and grantees have made tremendous strides in understanding the complex physiology of the bacteria that cause anthrax and plague, for example. The mechanism of pathogenesis of Ebola virus and other agents.is also better understood.

In addition, rapid progress in determining the genetic blueprints of dangerous pathogens has provided a wealth of information on the underlying biology of those organisms.


'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
14-Mar-2002


Page: 1 2 3 4

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID takes next genome step
3. NIAID awards grant to rapidly sequence the malaria mosquito genome
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Pacific Northwest team unveils largest virus proteome to date
9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2019)... LA JOLLA, Calif. (PRWEB) , ... May 01, ... ... of genomic tests that give families insight into their future children, announces a ... Cell-Free DNA ” in the journal of Pregnancy and Child Health. Previous studies ...
(Date:4/25/2019)... ... April 23, 2019 , ... Leak ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is pleased to ... Harbor Township, New Jersey. The new facility was custom designed to meet enhanced ...
(Date:4/25/2019)... ... April 24, 2019 , ... In a letter sent to ... collective of 62 individual scientists, bioethicists, and biotechnology executives, including past-presidents and current ... (ASGCT), across industry and academia called for collaboration on a binding global moratorium ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... ... May 13, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries’ is excited to announce the go-live ... LDA’s ability to communicate directly with the marketplace; serving as a destination to ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen Best ... being asked to store cellular products being used in adoptive therapy research ... world leaders, who have shared their expertise in building and managing facilities to ...
(Date:5/2/2019)... BELTSVILLE, Md. (PRWEB) , ... ... ... certification to the International Organization for Standardization ISO 9001:2015 standard, REPROCELL USA ... consistently meet customer requirements. In addition, REPROCELL USA Inc. aims to enhance ...
(Date:5/2/2019)... Calif. (PRWEB) , ... May 02, 2019 , ... ... clinical genetics testing company, will present results documenting discrepancies between U.S. insurer policies ... guidelines for patients at risk for hereditary breast and ovarian cancer (HBOC). ...
Breaking Biology Technology:
Cached News: